Rallybio Corp
RLYB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739410
No open-market purchases or sales by Rallybio Corp insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $65.0M in total; Viking Global Investors is the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Rallybio Corp changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 62 | 66 | +4 |
| Shares | 30.2M | 31.6M | +1.43M (+4.7%) |
| Value | $55.9M | $42.4M | −$13.5M (−24.1%) |
New holders (21)
Institutions that held Rallybio Corp at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Johnson & Johnson | 3,636,363 | $4.87M | 1.22% |
| Almitas Capital LLC | 100,876 | $135.2K | 0.06% |
| Y-Intercept (Hong Kong) Ltd | 94,484 | $126.6K | 0.01% |
| Centiva Capital, LP | 71,700 | $96.1K | 0.00% |
| Qube Research & Technologies Ltd | 54,201 | $72.6K | 0.00% |
| Two Sigma Investments, LP | 53,253 | $71.4K | 0.00% |
| Jane Street Group, LLC | 53,080 | $71.1K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 45,531 | $61.0K | 0.01% |
| HRT Financial LP | 24,971 | $33.0K | 0.00% |
| Two Sigma Advisers, LP | 24,500 | $32.8K | 0.00% |
| Schonfeld Strategic Advisors LLC | 18,800 | $25.2K | 0.00% |
| HSBC Holdings PLC | 17,531 | $24.7K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 16,270 | $21.8K | 0.00% |
| Point72 (DIFC) Ltd | 13,933 | $18.7K | 0.00% |
| Prelude Capital Management, LLC | 13,800 | $18.5K | 0.00% |
| Tudor Investment Corp Et Al | 10,367 | $13.9K | 0.00% |
| Catalyst Funds Management Pty Ltd | 7,800 | $10.5K | 0.00% |
| Hartford Financial Management Inc. | 6,500 | $8.71K | 0.00% |
| Cubist Systematic Strategies, LLC | 1,822 | $2.44K | 0.00% |
| Macquarie Group Ltd | 1,574 | $2.11K | 0.00% |
| CWM, LLC | 36 | $0 | 0.00% |
Sold out (17)
Institutions that held Rallybio Corp at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Blue Owl Capital Holdings LP | 350,240 | $647.9K |
| Bank of New York Mellon Corp | 90,316 | $167.1K |
| Charles Schwab Investment Management Inc | 77,018 | $142.5K |
| Nuveen Asset Management, LLC | 63,849 | $118.1K |
| Marshall Wace, LLP | 29,032 | $53.7K |
| XTX Topco Ltd | 22,791 | $42.2K |
| American International Group, Inc. | 15,067 | $27.9K |
| Capstone Investment Advisors, LLC | 10,900 | $20.2K |
| SG Americas Securities, LLC | 10,565 | $20.0K |
| Mercer Global Advisors Inc | 10,000 | $19.0K |
| California State Teachers Retirement System | 3,472 | $6.42K |
| Legal & General Group Plc | 2,946 | $5.46K |
| Ameritas Investment Partners, Inc. | 2,525 | $4.67K |
| STRS Ohio | 1,600 | $2.00K |
| Amalgamated Bank | 559 | $1.00K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 5 | $9 |
| Resources Management Corp | 250 | $0 |